News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Erika Hamilton/LinkedIn
May 9, 2025, 09:37

Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute, posted on LinkedIn:

“In advance of seeing some PROTAC data at ASCO25 in the MBC oral session, happy to share our review manuscript recently published for some background of how these anti-estrogen compounds work and why they are different from existing endocrine therapies.”

Title: PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

Authors: Erika P. Hamilton, Rinath M. Jeselsohn, Linda T. Vahdat, Sara A. Hurvitz

Read The Full Article at Springer Nature Link.

Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session

More posts featuring Erika Hamilton on OncoDaily.

ASCO25 Breast Cancer cancer Erika Hamilton Linda T. Vahdat OncoDaily Oncology PROTAC Rinath M. Jeselsohn Sara A. Hurvitz
Special Coverage
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues
Drugs
May 9, 2025, 07:19
Jenny Seligmann: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients
Career
May 9, 2025, 07:02
Vinay Prasad Appointed as the New Head of FDA's Center for Biologics Evaluation and Research